Scientists Question Data Behind an Experimental Alzheimer’s Drug
The New York Times
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
More Related News
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.